Operating review
The Group has begun 2024 with 5%
revenue growth (8% constant currency). Stripping out the benefit of
acquisitions, underlying sales revenue was down 3% at constant
currency as industrial and laboratory consumables markets adjusted
to lower inventory levels and more normal lead times through 2023
and into 2024. The Board's view is that underlying market growth
will be more evident in the second half.
Margins in those operations
affected by de-stocking have reduced modestly and foreign exchange
rates have had a £0.4 million adverse effect on adjusted profit.
Adjusted operating profit was nonetheless 2% ahead of the prior
period. Cash generation was as expected, leaving net cash
reserves of £4.1 million at 31 May 2024, having completed the
acquisition of the European Filter Corporation ("EFC") in the first
trading week of the new financial year.
Trading has been mixed across
segments. Stronger demand in aerospace and petrochemical
markets has continued. Both have reassuring order books into 2025.
Laboratory consumables businesses started to see more consistent
order patterns in the second quarter. Demand for industrial
consumables, notably in the US, remained patchy for most of the
period.
Inconsistency in trading patterns
across the Group is not unusual. We serve a range of markets in
different parts of the world and trading can be affected by both
local and global events. Despite this natural variation Porvair
benefits from underlying growth trends that have not changed:
tightening environmental regulation; the growth of analytical
science; the need for clean water; the development of
carbon-efficient transportation; the replacement of plastic and
steel by aluminium; and the drive for manufacturing process quality
and efficiency.
Financial summary
|
H1 2024
|
|
H1
2023
|
|
Growth
|
|
£m
|
|
£m
|
|
%
|
Revenue
|
94.6
|
|
90.6
|
|
5
|
Operating profit
|
11.6
|
|
11.7
|
|
(1)
|
Adjusted operating
profit*
|
12.5
|
|
12.2
|
|
2
|
Profit before tax
|
10.6
|
|
11.2
|
|
(6)
|
Adjusted profit before
tax*
|
11.5
|
|
11.8
|
|
(3)
|
|
|
|
|
|
|
|
Pence
|
|
Pence
|
|
|
Earnings per share
|
18.1
|
|
19.3
|
|
(6)
|
Adjusted earnings per
share*
|
19.5
|
|
20.3
|
|
(4)
|
|
|
|
|
|
|
|
£m
|
|
£m
|
|
|
Cash generated from
operations
|
7.1
|
|
8.2
|
|
|
Net closing cash (excluding lease
liabilities)
|
4.1
|
|
19.7
|
|
|
*See notes 1, 2 and 3 for
definitions and reconciliations.
Strategy and purpose
Porvair's strategy and purpose
have remained consistent for over 20 years, a period that
encompasses two recessions and a pandemic. The Group's record
for growth, cash generation and investment is:
|
5 years
|
|
10 years
|
15 years
|
Revenue CAGR*
|
5%
|
|
6%
|
8%
|
Earnings per share CAGR*
|
7%
|
|
9%
|
18%
|
Adjusted earnings per share
CAGR*
|
7%
|
|
10%
|
16%
|
* Compound annual growth
rate
|
|
|
|
|
|
5 years
|
|
10 years
|
15 years
|
£m
|
|
£m
|
£m
|
Cash from operations
|
101.2
|
|
168.3
|
212.7
|
Investment in acquisitions and
capital expenditure
|
60.0
|
|
102.3
|
118.3
|
This longer-term growth record
gives the Board confidence in the Group's capabilities and is the
basis for capital allocation and planning decisions.
Strategic statement and business model
Porvair's strategic purpose is the
development of specialist filtration,
laboratory and environmental technology businesses for the benefit
of all stakeholders. Principal measures of success include
consistent earnings growth and selected ESG measures. The
Group publishes a full ESG report at the time of the annual
financial results.
The Group is positioned to benefit
from global trends as outlined above.
Porvair businesses have certain
key characteristics in common:
· specialist design, engineering or commercial skills are
required;
· product use and replacement is mandated by regulation,
quality accreditation or a maintenance cycle; and
· products are typically designed into a system that will have
a long life-cycle and must perform to a given
specification.
Orders are won by offering the
best technical solutions or commercial service at an acceptable
cost. Technical expertise is necessary in all markets served.
New products are often adaptations of existing designs with
attributes validated in our own test and measurement laboratories.
Experience in specific markets and applications is valuable
in building customer confidence. Domain knowledge is
important, as is deciding where to direct resources.
This leads the Group
to:
· focus on markets with long-term growth potential;
· look
for applications where product use is mandated and replacement
demand is regular;
· make
new product development a core business activity;
· establish geographic presence where end-markets require;
and
· invest in both organic and acquired growth.
Therefore:
· we
focus on three operating segments: Aerospace & Industrial;
Laboratory; and Metal Melt Quality. All have clear long-term
growth drivers;
· our
products typically reduce emissions or protect complex downstream
systems and, as a result, are replaced regularly. A high
proportion of our annual revenue is from repeat orders;
· through a focus on new product development, we aim to
generate growth rates in excess of the underlying market.
Where possible, we build intellectual property around our product
developments;
· our
geographic presence follows the markets we serve. In the last
twelve months: 46% of revenue was in the Americas; 17% in Asia; 25% in Continental
Europe; 11% in the UK; and 1% in Africa. The Group has
plants in the US, UK, Belgium, Germany, Hungary, the Netherlands,
India and China. In the last twelve months:
48% of revenue was
manufactured in the US; 26% in the UK; 23% in Continental Europe;
3% in Asia; and
· we
aim to meet dividend and investment needs from free cash flow and
modest borrowing facilities. In recent years we have expanded
manufacturing capacity in the UK, Germany, US and China, and made
several acquisitions. All investments are subject to a hurdle
rate analysis based on strategic and financial
priorities.
Environmental, Social and Governance
("ESG")
The Board understands that
responsible business development is essential for creating
long-term value for stakeholders. Most of the products made
by Porvair are used to the benefit of the environment. Our
water analysis equipment measures contamination levels in
water. Industrial filters are typically needed to reduce
emissions or improve efficiency. Aerospace filters improve
safety and reliability. Nuclear filters confine fissile
materials. Metal Melt Quality filters reduce waste and help
improve the strength to weight ratio of metal
components.
A full ESG report was published in
February 2024 setting out:
· Porvair's ESG management framework and goals;
· how
climate change and a net zero carbon future might affect markets
served by the Group;
· ESG
metrics and results; and
· how
the Group acted for the benefits of its stakeholders in
2023.
This ESG report will be updated in
February 2025.
Divisional review
Aerospace & Industrial
|
H1 2024
|
|
H1
2023
|
|
Growth
|
|
£m
|
|
£m
|
|
%
|
Revenue
|
40.4
|
|
36.5
|
|
11
|
Operating profit
|
5.3
|
|
5.1
|
|
3
|
Adjusted operating
profit*
|
5.9
|
|
5.4
|
|
9
|
*See notes 1 and 2 for definitions
and reconciliations.
The Aerospace & Industrial
division designs and manufactures a wide range of specialist
filtration products, demand for which is driven by customers
seeking better engineered, cleaner, safer or more efficient
operations. Differentiation is achieved through design
engineering; the development of intellectual property; quality
accreditations; and customer service.
Revenue in the period increased by
11%. Aerospace
revenue was ahead 15%. Petrochemical sales, which can be lumpy,
were up 43%. US industrial consumable demand was lower,
offset in the period by a strong start by EFC, which was acquired
in December. HRW, acquired earlier in 2023, improved margins in the
microelectronics segment, wherein demand seems to be improving. The
general industrial factories were busier in the second quarter,
with work due to ship in the second half.
Laboratory
|
|
H1 2024
|
|
H1
2023
|
|
Growth
|
|
|
£m
|
|
£m
|
|
%
|
Revenue
|
|
32.1
|
|
29.1
|
|
10
|
Operating profit
|
|
4.2
|
|
4.7
|
|
(11)
|
Adjusted operating
profit*
|
|
4.5
|
|
4.9
|
|
(8)
|
*See notes 1 and 2 for definitions
and reconciliations.
The Laboratory division has two
operating businesses: Porvair Sciences (including Finneran,
Kbiosystems and, from July 2023, Ratiolab) and Seal
Analytical.
· Porvair Sciences manufactures laboratory filters, small
instruments and associated consumables, for which demand is driven
by sample preparation in analytical laboratories.
Differentiation is achieved through proprietary manufacturing
capabilities; control of filtration media; and customer
service.
· Seal
Analytical supplies instruments and consumables to environmental
laboratories, for which demand is driven by water quality
regulations. Differentiation is achieved through consistent
new product development focused on improving detection limits, and
improving laboratory automation.
A return to sales growth in the
first half of 2024 was as expected, helped by a maiden contribution
from Ratiolab, which was acquired in July 2023. The sales and
margin delivered in the first half of 2024 are almost identical to
those of the second half of 2023 with margins in both periods
around 14%. As integration costs associated with Ratiolab fall
away, we expect margins in the division to improve to more normal
levels.
Investments in the new plant in
Hungary and new product development in Seal continued unabated and
both will start to deliver returns in the balance of the
year.
Metal Melt Quality
|
H1 2024
|
|
H1
2023
|
|
Growth
|
|
£m
|
|
£m
|
|
%
|
Revenue
|
22.1
|
|
24.9
|
|
(11)
|
Operating profit
|
3.5
|
|
3.7
|
|
(4)
|
Adjusted operating
profit*
|
3.5
|
|
3.7
|
|
(4)
|
*See notes 1 and 2 for definitions
and reconciliations.
The Metal Melt Quality division
manufactures filters for molten aluminium, ductile iron and
nickel-cobalt alloys. It has a well-differentiated product
range based on patented products and extensive experience in melt
quality assessment.
Revenue fell 11% with de-stocking
in US markets reducing demand compared with a strong start to the
prior year. This was partially offset by robust demand for turbine
blade filters and revenue growth at the Chinese plant.
Margin management, operational
discipline and a better product mix improved margins, with
operating profits 4% lower.
Alternative performance measures - profit
|
H1 2024
|
|
H1
2023
|
|
Growth
|
|
£m
|
|
£m
|
|
%
|
Adjusted operating profit
|
12.5
|
|
12.2
|
|
2
|
Adjusted profit before
tax
|
11.5
|
|
11.8
|
|
(3)
|
Adjusted profit after tax
|
9.0
|
|
9.3
|
|
(4)
|
The Group presents alternative
performance measures to enable a better understanding of its
trading performance (see note 1). Adjusted operating profit
and adjusted profit before tax exclude items that are considered
significant and where treatment as an adjusting item provides a
more consistent assessment of the Group's trading
performance. Adjusting items comprise £0.9 million (2023:
£0.4 million) for the amortisation of acquired intangible assets
and £nil (2023: £0.2 million) for other acquisition-related costs
(see note 1).
Finance costs
Net finance costs of £1.0 million
(2023: £0.4 million) comprise interest on borrowings; lease
liabilities; and the Group's retirement benefit obligations;
together with the cost of unwinding discounts on provisions and
other payables. The Group also incurs undrawn commitment fees
on available banking facilities. Net finance costs increased in the
period, primarily due to interest on borrowings and the lease
liability interest associated with a property lease renewal in the
UK and the leased properties acquired within both Ratiolab and
EFC.
Tax
The total Group tax charge was
£2.3 million (2023: £2.4 million), including the tax effect of the
adjusting items set out in note 1. The adjusted tax charge
was £2.5 million (2023: £2.4 million), with the effective rate of
income tax on adjusted profit before tax at 22% (2023:
21%).
Earnings per share and dividends
The basic earnings per share for
the period was 18.1 pence (2023: 19.3
pence). Adjusted earnings per share was 19.5 pence (2023:
20.3 pence).
The Board has declared an interim
dividend of 2.1 pence (2023: 2.0 pence) per share.
Investment
In the last five years, £60.0
million has been invested in acquisitions and capital
expenditure. During the period, the Group invested £10.2
million (net of cash acquired) on the acquisition of EFC and £2.5
million on capital expenditure (2023: £2.9 million).
Cash flow, cash and net debt
Cash generated from operations in
the six months to 31 May 2024 was £7.1 million (2023: £8.2
million). The Group normally sees an outflow of working
capital in the first half of the year. Working capital
increased by £7.0 million (2023: £5.0 million) in the
period.
Net cash (excluding lease
liabilities) at 31 May 2024 was £4.1 million (31 May 2023: £19.7
million; 30 November 2023: £14.1 million), comprising cash of £14.2
million; bank overdrafts of £2.3 million and borrowings of £7.8
million. The borrowings were drawn to fund the acquisition of
EFC and are expected to be repaid in the second half. Lease
liabilities were £18.7 million (31 May 2023: £11.0 million; 30
November 2023: £13.4 million).
Return on capital employed
The Group's return on capital
employed was 14% (2023: 16%).
Excluding the impact of goodwill and retirement benefit
obligations, the return on operating capital employed was 31%
(2023: 37%).
CEO succession
As announced on 16 April 2024 Ben
Stocks has notified the Board of his decision to retire in early
2025. The search for a successor is progressing well and further
updates will be provided as appropriate.
Outlook
2024 is unfolding as expected.
Over the first six months, strength in aerospace and petrochemical
markets, helped by the benefit of 2024 acquisitions, has offset
weakness in industrial and laboratory consumables and foreign
exchange headwinds. This has been in line with management
expectations. The trading outlook for the second half of the year
is positive. Order books across the Group are strengthening with
lead times now returned to more traditional levels. The benefits of
the 2023 acquisitions continue to come through, and several larger
petrochemical orders will start to ship towards the end of the
year.
The Group's fundamental demand
drivers have not changed. Porvair remains well positioned to take
advantage of tightening environmental regulation; the growth of
analytical science; the need for clean water; the development of
carbon-efficient transportation; the replacement of plastic and
steel by aluminium; and the drive for manufacturing process quality
and efficiency. It is these trends that have driven the Group's
consistent longer-term trading record. The Board expects a healthy
second half which will allow the Group to move into 2025 in good
shape.
Ben
Stocks
Group Chief Executive
28 June 2024
Related parties
Other than remuneration of key
management personnel, there were no related party transactions in
the six months ended 31 May 2024 (2023: none).
Principal risks
Each division considers strategic,
operational and financial risks and identifies actions to mitigate
those risks. These risk profiles are reviewed by the Board
and updated at least annually. Further details of the Group's
risk profile analysis can be found in the Strategic Report section
of the Annual Report & Accounts for the year ended 30 November
2023.
Certain elements of the Group's
order position can change quickly in the face of changing economic
circumstances. The Metal Melt Quality division, Laboratory
division and general industrial filtration within the Aerospace
& Industrial division all have relatively short lead times and
order cycles and, therefore, revenue is subject to fluctuations
which could have a material effect on the Group's results for the
balance of 2024.
Forward-looking statements
Certain statements in this interim
financial information are forward-looking. Although the Group
believes that the expectations reflected in these forward-looking
statements are reasonable, it can give no assurance that these
expectations will prove to be correct. Because these
statements involve risks and uncertainties, actual results may
differ materially from those expressed or implied by these
forward-looking statements.
We undertake no obligation to
update any forward-looking statements, whether as a result of new
information, future events or otherwise.
Condensed consolidated income statement
For
the six months ended 31 May
|
|
|
Six months ended 31
May
|
|
|
|
2024
|
|
2023
|
|
Note
|
|
Unaudited
|
|
Unaudited
|
Continuing operations
|
|
|
£'000
|
|
£'000
|
Revenue
|
1,2
|
|
94,639
|
|
90,552
|
Cost of sales
|
|
|
(61,346)
|
|
(59,924)
|
Gross profit
|
|
|
33,293
|
|
30,628
|
Other operating
expenses
|
|
|
(21,708)
|
|
(18,975)
|
Adjusted operating profit
|
1,2
|
|
12,468
|
|
12,226
|
Adjustments:
|
|
|
|
|
|
Amortisation of acquired intangible assets
|
|
|
(883)
|
|
(370)
|
Other acquisition-related costs
|
|
|
-
|
|
(203)
|
Operating profit
|
1,2
|
|
11,585
|
|
11,653
|
Finance costs
|
|
|
(1,013)
|
|
(437)
|
Profit before tax
|
|
|
10,572
|
|
11,216
|
Adjusted income tax expense
|
|
|
(2,472)
|
|
(2,449)
|
Adjustments:
|
|
|
|
|
|
Tax effect of adjustments to operating
profit
|
1
|
|
209
|
|
82
|
Income tax expense
|
|
|
(2,263)
|
|
(2,367)
|
Profit for the period
|
|
|
8,309
|
|
8,849
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings per share (basic)
|
3
|
|
18.1p
|
|
19.3p
|
Earnings per share (diluted)
|
3
|
|
18.1p
|
|
19.3p
|
|
|
|
|
|
|
Adjusted earnings per share (basic)
|
3
|
|
19.5p
|
|
20.3p
|
Adjusted earnings per share (diluted)
|
3
|
|
19.5p
|
|
20.3p
|
Condensed consolidated statement of comprehensive
income
For
the six months ended 31 May
|
|
Six months ended 31
May
|
|
|
2024
Unaudited
£'000
|
|
2023
Unaudited
£'000
|
|
|
|
Profit for the period
|
|
8,309
|
|
8,849
|
Other comprehensive income/(expense)
|
|
|
|
|
Items that will not be reclassified to profit and
loss:
|
|
|
|
|
Actuarial gain in defined benefit
pension plans net of
tax
|
132
|
|
750
|
Items that may be subsequently reclassified to profit and
loss:
|
|
|
|
Exchange loss on translation of
foreign subsidiaries
|
(682)
|
|
(2,751)
|
Total other comprehensive expense for the
period
|
(550)
|
|
(2,001)
|
Total comprehensive income for the period
|
|
7,759
|
|
6,848
|
|
|
|
|
|
|
|
|
|
| |
The accompanying notes are an
integral part of this interim financial
information.
Condensed consolidated balance sheet
As
at 31 May
|
|
As at 31
May
|
|
As at
30 November
|
|
Note
|
2024
Unaudited
|
|
2023
Unaudited
|
|
2023
Audited
|
|
|
£'000
|
|
£'000
|
|
£'000
|
Non-current assets
|
|
|
|
|
|
|
Property, plant and
equipment
|
|
28,795
|
|
24,710
|
|
28,329
|
Right-of-use assets
|
|
17,208
|
|
9,614
|
|
12,136
|
Goodwill and other intangible
assets
|
|
91,242
|
|
76,470
|
|
82,949
|
Deferred tax asset
|
|
163
|
|
740
|
|
401
|
|
|
137,408
|
|
111,534
|
|
123,815
|
Current assets
|
|
|
|
|
|
|
Inventories
|
|
32,480
|
|
32,803
|
|
31,898
|
Trade and other
receivables
|
|
32,405
|
|
26,278
|
|
23,268
|
Derivative financial
instruments
|
|
185
|
|
335
|
|
250
|
Cash and cash equivalents
|
8
|
14,240
|
|
19,678
|
|
16,839
|
|
|
79,310
|
|
79,094
|
|
72,255
|
|
|
|
|
|
|
|
Current liabilities
|
|
|
|
|
|
|
Trade and other payables
|
|
(27,420)
|
|
(28,664)
|
|
(23,827)
|
Bank overdrafts
|
8
|
(2,266)
|
|
-
|
|
(2,787)
|
Borrowings
|
8
|
(7,849)
|
|
-
|
|
-
|
Current tax liabilities
|
|
(1,235)
|
|
(572)
|
|
(594)
|
Lease liabilities
|
|
(1,763)
|
|
(2,046)
|
|
(2,057)
|
Provisions
|
5
|
(2,862)
|
|
(4,028)
|
|
(3,243)
|
|
|
(43,395)
|
|
(35,310)
|
|
(32,508)
|
Net
current assets
|
|
35,915
|
|
43,784
|
|
39,747
|
|
|
|
|
|
|
|
Non-current liabilities
|
|
|
|
|
|
|
Deferred tax liability
|
|
(3,903)
|
|
(2,698)
|
|
(3,583)
|
Retirement benefit
obligations
|
|
(5,536)
|
|
(6,759)
|
|
(7,713)
|
Other payables
|
|
-
|
|
-
|
|
(123)
|
Lease liabilities
|
|
(16,956)
|
|
(8,968)
|
|
(11,342)
|
Provisions
|
5
|
(324)
|
|
(345)
|
|
(363)
|
|
|
(26,719)
|
|
(18,770)
|
|
(23,124)
|
Net
assets
|
|
146,604
|
|
136,548
|
|
140,438
|
|
|
|
|
|
|
|
Capital and reserves
|
|
|
|
|
|
|
Share capital
|
|
927
|
|
927
|
|
927
|
Share premium account
|
|
37,784
|
|
37,778
|
|
37,778
|
Cumulative translation
reserve
|
|
10,143
|
|
12,702
|
|
10,825
|
Retained earnings
|
|
97,750
|
|
85,141
|
|
90,908
|
Equity attributable to owners of the parent
|
146,604
|
|
136,548
|
|
140,438
|
The interim financial information
was approved by the Board of Directors on 28 June 2024 and was
signed on its behalf by:
Ben
Stocks
James Mills
Group Chief
Executive
Group Finance Director
The accompanying notes are an
integral part of this interim financial information.
Condensed consolidated cash flow statement
For
the six months ended 31 May
|
|
Six months ended 31
May
|
|
Note
|
2024
Unaudited
|
|
2023
Unaudited
|
|
|
£'000
|
|
£'000
|
Cash flows from operating activities
|
|
|
|
|
Cash generated from
operations
|
7
|
7,120
|
|
8,211
|
Interest paid
|
|
(394)
|
|
(154)
|
Tax paid
|
|
(1,783)
|
|
(2,057)
|
Net cash generated from operating
activities
|
|
4,943
|
|
6,000
|
|
|
|
|
|
Cash flows from investing activities
|
|
|
|
|
Interest received
|
|
1
|
|
39
|
Acquisition of subsidiaries (net of
cash acquired)
|
9
|
(10,166)
|
|
(678)
|
Purchase of property, plant and
equipment
|
|
(2,368)
|
|
(2,221)
|
Purchase of intangible
assets
|
|
(143)
|
|
(30)
|
Net cash used in investing activities
|
|
(12,676)
|
|
(2,890)
|
|
|
|
|
|
Cash flows from financing activities
|
|
|
|
|
Proceeds from issue of ordinary
shares
|
|
6
|
|
152
|
Purchase of Employee Benefit Trust
shares
|
|
(319)
|
|
(372)
|
Increase in borrowings
|
8
|
10,720
|
|
-
|
Decrease in borrowings
|
8
|
(2,871)
|
|
-
|
Repayment of lease
liabilities
|
|
(1,803)
|
|
(1,259)
|
Net
cash generated from/(used in) financing
activities
|
|
5,733
|
|
(1,479)
|
|
|
|
|
|
Net
(decrease)/increase in cash and cash equivalents
|
8
|
(2,000)
|
|
1,631
|
Effects of exchange rate
changes
|
(78)
|
|
(250)
|
|
|
(2,078)
|
|
1,381
|
Cash and cash equivalents at the
beginning of the period
|
|
14,052
|
|
18,297
|
Cash and cash equivalents at the end of the
period
|
8
|
11,974
|
|
19,678
|
The accompanying notes are an
integral part of this interim financial information.
Condensed consolidated statement of changes in
equity
For
the six months ended 31 May (unaudited)
|
Share
capital
£'000
|
Share premium
account
£'000
|
Cumulative translation
reserve
£'000
|
Retained
earnings
£'000
|
Total
equity
£'000
|
At 1 December 2022
|
927
|
37,626
|
15,453
|
77,062
|
131,068
|
Profit for the period
|
-
|
-
|
-
|
8,849
|
8,849
|
Other comprehensive
(expense)/income
|
-
|
-
|
(2,751)
|
750
|
(2,001)
|
Total comprehensive
(expense)/income for the period
|
-
|
-
|
(2,751)
|
9,599
|
6,848
|
Purchase of own shares (held in
trust)
|
-
|
-
|
-
|
(372)
|
(372)
|
Issue of ordinary share
capital
|
-
|
152
|
-
|
-
|
152
|
Share-based payments (net of
tax)
|
-
|
-
|
-
|
597
|
597
|
Dividends
|
-
|
-
|
-
|
(1,745)
|
(1,745)
|
At 31 May 2023
|
927
|
37,778
|
12,702
|
85,141
|
136,548
|
At 1 December 2023
|
927
|
37,778
|
10,825
|
90,908
|
140,438
|
Profit for the period
|
-
|
-
|
-
|
8,309
|
8,309
|
Other comprehensive
(expense)/income
|
-
|
-
|
(682)
|
132
|
(550)
|
Total comprehensive
(expense)/income for the period
|
-
|
-
|
(682)
|
8,441
|
7,759
|
Purchase of own shares (held in
trust)
|
-
|
-
|
-
|
(319)
|
(319)
|
Issue of ordinary share
capital
|
-
|
6
|
-
|
-
|
6
|
Share-based payments (net of
tax)
|
-
|
-
|
-
|
562
|
562
|
Dividends
|
-
|
-
|
-
|
(1,842)
|
(1,842)
|
At 31 May 2024
|
927
|
37,784
|
10,143
|
97,750
|
146,604
|
The accompanying notes are an
integral part of this interim financial information.
Notes
1.
Alternative performance measures
Alternative performance measures are
used by the Directors and management to monitor business
performance internally and exclude certain cash and non-cash items
which they believe are not reflective of the normal course of
business of the Group. The Directors believe that disclosing
such non-IFRS measures enables a reader to isolate and evaluate the
impact of such items on results and allows for a fuller
understanding of performance from year to year. Alternative
performance measures may not be directly comparable with other
similarly titled measures used by other companies.
Alternative revenue measures (unaudited)
|
|
Six months ended 31
May
|
|
|
|
|
2024
|
|
2023
|
|
Growth
|
Aerospace & Industrial
|
|
£'000
|
|
£'000
|
|
%
|
Underlying revenue
|
|
34,297
|
|
34,503
|
|
(1)
|
Acquisition
|
|
4,916
|
|
-
|
|
|
Revenue at constant
currency
|
|
39,213
|
|
34,503
|
|
14
|
Exchange
|
|
1,221
|
|
2,037
|
|
|
Revenue as reported
|
|
40,434
|
|
36,540
|
|
11
|
|
|
|
|
|
|
|
Laboratory
|
|
|
|
|
|
|
Underlying revenue
|
|
26,090
|
|
26,964
|
|
(3)
|
Acquisition
|
|
4,247
|
|
-
|
|
|
Revenue at constant
currency
|
|
30,337
|
|
26,964
|
|
13
|
Exchange
|
|
1,732
|
|
2,163
|
|
|
Revenue as reported
|
|
32,069
|
|
29,127
|
|
10
|
|
|
|
|
|
|
|
Metal Melt Quality
|
|
|
|
|
|
|
Revenue at constant
currency
|
|
20,028
|
|
21,655
|
|
(8)
|
Exchange
|
|
2,108
|
|
3,230
|
|
|
Revenue as reported
|
|
22,136
|
|
24,885
|
|
(11)
|
|
|
|
|
|
|
|
Group
|
|
|
|
|
|
|
Underlying revenue
|
|
80,415
|
|
83,122
|
|
(3)
|
Acquisitions
|
|
9,163
|
|
-
|
|
|
Revenue at constant
currency
|
|
89,578
|
|
83,122
|
|
8
|
Exchange
|
|
5,061
|
|
7,430
|
|
|
Revenue as reported
|
|
94,639
|
|
90,552
|
|
5
|
Revenue at constant currency is
derived from translating overseas subsidiaries results at budgeted
fixed exchange rates. In 2024 and 2023, the rates used were
US$1.40:£1 and €1.20:£1, compared with actual rates of US$1.27:£1
(2023: US$1.22:£1) and €1.17:£1 (2023: €1.14:£1).
Underlying revenue is revenue at
constant currency adjusted for the impact of acquisitions made in
the current period and prior year.
The acquisition lines relate to
the revenue from Ratiolab and EFC, acquired in July 2023 and
December 2023 respectively.
Alternative profit measures (unaudited)
A reconciliation of the Group's
adjusted performance measures to the reported IFRS measures is
presented below:
|
|
|
H1 2024
|
|
|
|
H1
2023
|
|
|
|
Adjusted
|
Adjustments
|
Reported
|
|
Adjusted
|
Adjustments
|
Reported
|
|
|
£'000
|
£'000
|
£'000
|
|
£'000
|
£'000
|
£'000
|
Operating profit
|
12,468
|
(883)
|
11,585
|
|
12,226
|
(573)
|
11,653
|
Finance costs
|
(1,013)
|
-
|
(1,013)
|
|
(437)
|
-
|
(437)
|
Profit before tax
|
11,455
|
(883)
|
10,572
|
|
11,789
|
(573)
|
11,216
|
Income tax expense
|
(2,472)
|
209
|
(2,263)
|
|
(2,449)
|
82
|
(2,367)
|
Profit for the period
|
8,983
|
(674)
|
8,309
|
|
9,340
|
(491)
|
8,849
|
|
|
|
|
|
|
|
| |
An analysis of adjusting items is
given below:
|
2024
|
|
2023
|
Affecting operating profit:
|
£'000
|
|
£'000
|
Amortisation of acquired intangible assets
|
(883)
|
|
(370)
|
Other acquisition-related costs
|
-
|
|
(203)
|
|
(883)
|
|
(573)
|
Affecting tax:
|
|
|
|
Tax effect of adjustments to operating
profit
|
209
|
|
82
|
Total adjusting items
|
(674)
|
|
(491)
|
Adjusted operating profit
excludes:
· the
amortisation of intangible assets arising on acquisition of
businesses of £0.9 million (2023: £0.4 million); and
· other acquisition-related costs of £nil (2023: £0.2 million)
incurred in relation to the acquisition of certain business and
assets from HRW acquired in March 2023; the 100% share capital of
Ratiolab acquired in July 2023; and the 100% share capital of EFC
acquired in December 2023 (note 9).
2. Segmental
information
The chief operating decision maker
has been identified as the Board of Directors. The Board of
Directors has instructed the Group's internal reporting to be based
around differences in products and services, in order to assess
performance and allocate resources. The key profit measure
used to assess the performance of each reportable segment is
adjusted operating profit/(loss). Management has determined
the operating segments based on this reporting.
As at 31 May 2024, the Group is
organised on a worldwide basis into three operating
segments:
1) Aerospace &
Industrial - principally serving the aviation, and energy and
industrial markets;
2) Laboratory -
principally serving the bioscience and environmental laboratory
instrument and consumables market; and
3) Metal Melt Quality
- principally serving the global aluminium, North American Free
Trade Agreement ("NAFTA") iron foundry and superalloys
markets.
Other Group operations' costs,
assets and liabilities are included in the "Central"
division. Central costs mainly
comprise Group corporate costs, including new business development
costs, some research and development costs and general financial
costs. Central assets and liabilities mainly comprise Group
retirement benefit obligations, tax assets and liabilities, cash
and borrowings.
The segment results for the period
ended 31 May 2024 are as follows:
2024 - Unaudited
|
Aerospace
& Industrial
|
|
Laboratory
|
|
Metal Melt
Quality
|
|
Central
|
|
Group
|
|
£'000
|
|
£'000
|
|
£'000
|
|
£'000
|
|
£'000
|
Total segment revenue
|
40,434
|
|
32,689
|
|
22,136
|
|
-
|
|
95,259
|
Inter-segment revenue
|
-
|
|
(620)
|
|
-
|
|
-
|
|
(620)
|
Revenue
|
40,434
|
|
32,069
|
|
22,136
|
|
-
|
|
94,639
|
|
|
|
|
|
|
|
|
|
|
Adjusted operating
profit/(loss)
|
5,846
|
|
4,521
|
|
3,565
|
|
(1,464)
|
|
12,468
|
Amortisation of acquired intangible assets
|
(573)
|
|
(310)
|
|
-
|
|
-
|
|
(883)
|
Operating profit/(loss)
|
5,273
|
|
4,211
|
|
3,565
|
|
(1,464)
|
|
11,585
|
Finance costs
|
-
|
|
-
|
|
-
|
|
(1,013)
|
|
(1,013)
|
Profit/(loss) before tax
|
5,273
|
|
4,211
|
|
3,565
|
|
(2,477)
|
|
10,572
|
The segment results for the period
ended 31 May 2023 are as follows:
2023 - Unaudited
|
Aerospace
& Industrial
|
|
Laboratory
|
|
Metal Melt
Quality
|
|
Central
|
|
Group
|
|
£'000
|
|
£'000
|
|
£'000
|
|
£'000
|
|
£'000
|
Total segment revenue
|
36,553
|
|
30,076
|
|
24,885
|
|
-
|
|
91,514
|
Inter-segment revenue
|
(13)
|
|
(949)
|
|
-
|
|
-
|
|
(962)
|
Revenue
|
36,540
|
|
29,127
|
|
24,885
|
|
-
|
|
90,552
|
|
|
|
|
|
|
|
|
|
|
Adjusted operating profit/(loss)
|
5,359
|
|
4,898
|
|
3,715
|
|
(1,746)
|
|
12,226
|
Amortisation of acquired intangible assets
|
(217)
|
|
(153)
|
|
-
|
|
-
|
|
(370)
|
Other acquisition-related costs
|
-
|
|
-
|
|
-
|
|
(203)
|
|
(203)
|
Operating profit/(loss)
|
5,142
|
|
4,745
|
|
3,715
|
|
(1,949)
|
|
11,653
|
Finance costs
|
-
|
|
-
|
|
-
|
|
(437)
|
|
(437)
|
Profit/(loss) before
tax
|
5,142
|
|
4,745
|
|
3,715
|
|
(2,386)
|
|
11,216
|
The segment assets and liabilities
at 31 May 2024 are as follows:
At
31 May 2024 - Unaudited
|
Aerospace
& Industrial
|
|
Laboratory
|
|
Metal Melt
Quality
|
|
Central
|
|
Group
|
|
£'000
|
|
£'000
|
|
£'000
|
|
£'000
|
|
£'000
|
Segmental assets
|
87,009
|
|
77,913
|
|
34,930
|
|
2,626
|
|
202,478
|
Cash and cash
equivalents
|
-
|
|
-
|
|
-
|
|
14,240
|
|
14,240
|
Total assets
|
87,009
|
|
77,913
|
|
34,930
|
|
16,866
|
|
216,718
|
|
|
|
|
|
|
|
|
|
|
Segmental liabilities
|
(27,607)
|
|
(13,602)
|
|
(4,862)
|
|
(8,392)
|
|
(54,463)
|
Retirement benefit
obligations
|
-
|
|
-
|
|
-
|
|
(5,536)
|
|
(5,536)
|
Bank overdrafts
|
-
|
|
-
|
|
-
|
|
(2,266)
|
|
(2,266)
|
Borrowings
|
-
|
|
-
|
|
-
|
|
(7,849)
|
|
(7,849)
|
Total liabilities
|
(27,607)
|
|
(13,602)
|
|
(4,862)
|
|
(24,043)
|
|
(70,114)
|
The segment assets and liabilities
at 31 May 2023 are as follows:
At
31 May 2023 - Unaudited
|
Aerospace
& Industrial
|
|
Laboratory
|
|
Metal Melt
Quality
|
|
Central
|
|
Group
|
|
|
£'000
|
|
£'000
|
|
£'000
|
|
£'000
|
|
£'000
|
|
Segmental assets
|
70,099
|
|
64,762
|
|
34,099
|
|
1,990
|
|
170,950
|
Cash and cash
equivalents
|
-
|
|
-
|
|
-
|
|
19,678
|
|
19,678
|
Total assets
|
70,099
|
|
64,762
|
|
34,099
|
|
21,668
|
|
190,628
|
|
|
|
|
|
|
|
|
|
|
Segmental liabilities
|
(20,488)
|
|
(13,498)
|
|
(6,587)
|
|
(6,748)
|
|
(47,321)
|
Retirement benefit
obligations
|
-
|
|
-
|
|
-
|
|
(6,759)
|
|
(6,759)
|
Total liabilities
|
(20,488)
|
|
(13,498)
|
|
(6,587)
|
|
(13,507)
|
|
(54,080)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
The segment assets and liabilities
at 30 November 2023 are as follows:
At
30 November 2023 - Audited
|
Aerospace
& Industrial
|
|
Laboratory
|
|
Metal Melt
Quality
|
|
Central
|
|
Group
|
|
£'000
|
|
£'000
|
|
£'000
|
|
£'000
|
|
£'000
|
Segmental assets
|
67,456
|
|
74,835
|
|
34,470
|
|
2,470
|
|
179,231
|
Cash and cash
equivalents
|
-
|
|
-
|
|
-
|
|
16,839
|
|
16,839
|
Total assets
|
67,456
|
|
74,835
|
|
34,470
|
|
19,309
|
|
196,070
|
|
|
|
|
|
|
|
|
|
|
Segmental liabilities
|
(18,709)
|
|
(13,533)
|
|
(6,301)
|
|
(6,589)
|
|
(45,132)
|
Retirement benefit
obligations
|
-
|
|
-
|
|
-
|
|
(7,713)
|
|
(7,713)
|
Bank overdrafts
|
-
|
|
-
|
|
-
|
|
(2,787)
|
|
(2,787)
|
Total liabilities
|
(18,709)
|
|
(13,533)
|
|
(6,301)
|
|
(17,089)
|
|
(55,632)
|
Geographical analysis
|
Six months ended 31
May
|
|
2024
Unaudited
|
|
2023
Unaudited
|
Revenue
|
By
destination
£'000
|
By origin
£'000
|
|
By
destination
£'000
|
By
origin
£'000
|
United Kingdom
|
9,308
|
23,363
|
|
8,975
|
24,018
|
Continental Europe
|
26,824
|
25,682
|
|
18,475
|
14,054
|
United States of America
|
39,665
|
43,074
|
|
43,250
|
49,701
|
Other NAFTA
|
2,212
|
-
|
|
2,204
|
-
|
South America
|
792
|
-
|
|
1,448
|
-
|
Asia
|
14,498
|
2,520
|
|
15,395
|
2,779
|
Africa
|
1,340
|
-
|
|
805
|
-
|
|
94,639
|
94,639
|
|
90,552
|
90,552
|
3. Earnings
per share (EPS)
|
Six months ended 31
May
|
|
2024
Unaudited
|
|
2023
Unaudited
|
As
reported
|
Earnings
£'000
|
Weighted average number of
shares
|
Per share
Pence
|
|
Earnings
£'000
|
Weighted
average number of shares
|
Per
share
Pence
|
Profit for the period -
attributable to owners of the parent
|
8,309
|
|
|
|
8,849
|
|
|
Shares in issue
|
|
46,355,562
|
|
|
|
46,343,604
|
|
Shares owned by the Employee
Benefit Trust
|
|
(367,852)
|
|
|
|
(410,009)
|
|
Basic EPS
|
8,309
|
45,987,710
|
18.1
|
|
8,849
|
45,933,595
|
19.3
|
Dilutive share options
outstanding
|
-
|
42,588
|
-
|
|
-
|
18,087
|
-
|
Diluted EPS
|
8,309
|
46,030,298
|
18.1
|
|
8,849
|
45,951,682
|
19.3
|
|
|
|
|
|
|
|
|
| |
In addition to the above, the Group
also calculates an EPS based on adjusted profit as the Board
believes this to be a better measure to judge the progress of the
Group, as discussed in note 1.
|
Six months ended 31
May
|
|
2024
|
|
2023
|
Adjusted
|
Earnings
£'000
|
Unaudited
Weighted average number of
shares
|
Per share
Pence
|
|
Earnings
£'000
|
Unaudited
Weighted
average number of shares
|
Per
share
Pence
|
Profit for the period -
attributable to owners of the parent
|
8,309
|
|
|
|
8,849
|
|
|
Adjusting items (note
1)
|
674
|
|
|
|
491
|
|
|
Adjusted profit -attributable to
owners of the parent
|
8,983
|
|
|
|
9,340
|
|
|
Adjusted Basic EPS
|
8,983
|
45,987,710
|
19.5
|
|
9,340
|
45,933,595
|
20.3
|
Adjusted Diluted EPS
|
|
46,030,298
|
19.5
|
|
9,340
|
45,951,682
|
20.3
|
4. Dividends per
share
|
Six months ended 31
May
|
|
2024
|
|
2023
|
|
Unaudited
|
|
Unaudited
|
|
Per share
Pence
|
£'000
|
|
Per
share
Pence
|
£'000
|
Final dividend approved
|
4.0
|
1,842
|
|
3.8
|
1,745
|
The final dividend approved for
the year ended 30 November 2023 was paid to shareholders on 5 June
2024.
The Directors have declared an
interim dividend of 2.1 pence (2023: 2.0 pence) per share to be
paid on 21 August 2024 to shareholders on the register at the close
of business on 19 July 2024; the ex-dividend date is 18 July
2024.
5.
Provisions
|
|
|
|
Dilapidations
£'000
|
|
Warranty
£'000
|
|
Total
£'000
|
At 1 December 2023
|
|
|
|
363
|
|
3,243
|
|
3,606
|
Additional charge in the
period
|
|
|
|
-
|
|
185
|
|
185
|
Utilisation of
provision
|
|
|
|
-
|
|
(212)
|
|
(212)
|
Release of provision
|
|
|
|
(62)
|
|
(347)
|
|
(409)
|
Unwinding of discount
|
|
|
|
23
|
|
-
|
|
23
|
Exchange
|
|
|
|
-
|
|
(7)
|
|
(7)
|
At
31 May 2024
|
|
|
|
324
|
|
2,862
|
|
3,186
|
Provisions arise from potential
claims on major contracts, sale warranties, and discounted
dilapidations for leased property. Matters that could affect the timing, quantum and extent to
which provisions are utilised or released include the impact of any
remedial work, claims against outstanding performance bonds, and
the demonstrated life of the filtration equipment
installed.
6. Contingent
liabilities
The Group has €2.8 million (31 May 2023: €0.8
million; 30 November 2023: €3.0 million) of unexpired advanced
payment and performance bonds issued in the ordinary course of
business. The advanced payment bonds are expected to expire
no later than July 2026 and the performance bonds no later than
October 2027.
7. Cash
generated from operations
|
|
Six months ended 31
May
|
|
|
2024
Unaudited
£'000
|
|
2023
Unaudited
£'000
|
Operating profit
|
|
11,585
|
|
11,653
|
Adjustments for:
|
|
|
|
|
Fair value movement of derivatives
through profit and loss
|
65
|
|
(100)
|
Share-based payments
|
|
532
|
|
552
|
Depreciation of property, plant
and equipment and amortisation of intangibles
|
2,904
|
|
2,127
|
Depreciation of right-of-use
assets
|
1,323
|
|
1,124
|
Operating cash flows before movement in working
capital
|
16,409
|
|
15,356
|
Decrease/(increase) in
inventories
|
|
192
|
|
(2,301)
|
Increase in trade and other
receivables
|
|
(7,718)
|
|
(2,313)
|
Increase/(decrease) in trade and
other payables
|
|
840
|
|
(734)
|
(Decrease)/increase in
provisions
|
|
(437)
|
|
351
|
Increase in working
capital
|
|
(7,123)
|
|
(4,997)
|
Post employment benefits (net cash
movement)
|
|
(2,166)
|
|
(2,148)
|
Cash generated from operations
|
|
7,120
|
|
8,211
|
8.
Reconciliation of net cash flow to movement
in net cash/(debt)
|
Six months ended 31
May
|
|
2024
Unaudited
£'000
|
|
2023
Unaudited
£'000
|
Net cash at the beginning of the
period
|
653
|
|
6,825
|
(Decrease)/increase in cash and
cash equivalents
|
(2,000)
|
|
1,631
|
Net movement in
borrowings
|
(7,849)
|
|
-
|
(Increase)/decrease in lease
liabilities
|
(5,426)
|
|
348
|
Effects of exchange rate
changes
|
28
|
|
(140)
|
Net (debt)/cash at the end of the period
|
(14,594)
|
|
8,664
|
Cash and cash equivalents
|
14,240
|
|
19,678
|
Bank overdraft
|
(2,266)
|
|
-
|
Borrowings
|
(7,849)
|
|
-
|
|
4,125
|
|
19,678
|
Lease liabilities
|
(18,719)
|
|
(11,014)
|
Net (debt)/cash at the end of the period
|
(14,594)
|
|
8,664
|
9.
Acquisition
On 4 December 2023, the Group
acquired 100% of the share capital of European Filter Corporation
NV ("EFC"), a filtration business based in Lummen,
Belgium. EFC has expertise in the
manufacture of mist elimination filters used in the production of
industrial feedstocks and well-established industrial filtration
sales channels in north east Europe. EFC joins the Group's
Aerospace & Industrial division, bringing complementary
products and engineering as well as strengthening European routes
to market.
The acquisition completed on a
cash free, debt free basis and subject to an agreed level of
working capital. Total cash consideration of £10.3 million
was paid in the period. In the period since acquisition, EFC has
contributed £4.9 million of revenue at
constant currency and £1.0 million of adjusted operating profit to
the Group results.
The following table sets out the
consideration paid, together with the provisional fair value of
assets acquired and liabilities assumed:
|
|
|
Total
|
|
|
|
£'000
|
Cash consideration
|
|
|
10,294
|
Provisional fair value of net assets
acquired (below)
|
|
|
(4,745)
|
Goodwill
|
|
|
5,549
|
|
|
|
Fair value
|
|
£'000
|
Property, plant and equipment
(including right-of-use assets)
|
2,344
|
Trademark, customer order book and
relationships (included within intangible assets)
|
4,092
|
Inventories
|
944
|
Trade and other
receivables
|
1,592
|
Cash and
cash equivalents
|
128
|
Trade and other payables
(including lease liabilities)
|
(3,554)
|
Deferred tax liability
|
(801)
|
Provisional fair value of net assets
acquired
|
|
|
4,745
|
|
|
|
|
An independent valuation of the
identifiable intangible assets has been carried out in the
period. The provisional value of acquired intangible assets
comprise trademarks of £0.6 million, a
customer order book of £0.2 million and customer relationships of
£3.3 million.
The goodwill is attributable to
non-contractual relationships, the synergies between the business
acquired and the operations of the Group, and the potential to
develop the technologies acquired. None of these meet the
criteria for recognition of intangible assets separable from
goodwill. The goodwill recognised is attributable to the
Aerospace & Industrial division and is not expected to be
deductible for income tax purposes.
These provisional fair values may
be adjusted in future in accordance with IFRS 3 Business Combinations.
10. Exchange
rates
Exchange rates for the US dollar and
Euro during the period were:
|
Average rate to 31 May
24
|
Average
rate to 31 May 23
|
Closing rate at 31 May
24
|
Closing
rate at 30 Nov 23
|
|
Unaudited
|
Unaudited
|
Unaudited
|
Unaudited
|
US dollar
|
1.27
|
1.22
|
1.27
|
1.27
|
Euro
|
1.17
|
1.14
|
1.17
|
1.16
|
11. Basis of
preparation
Porvair plc is a public limited
company registered in the UK and listed on the London Stock
Exchange.
This unaudited condensed interim
consolidated financial information for the six months ended 31 May
2024 has been prepared in accordance with the Disclosure and
Transparency Rules ('DTR') of the Financial Conduct Authority and
with IAS 34 Interim Financial
Reporting as contained in UK-adopted International
Accounting Standards. The condensed interim consolidated
financial information should be read in conjunction with the annual
financial statements for the year ended 30 November 2023, which
were prepared in accordance with applicable law and UK-adopted
International Accounting Standards.
The accounting policies applied in
these interim financial statements are consistent with those
applied in the Group's consolidated financial statements for the
year ended 30 November 2023. A number of new amendments are
effective from 1 December 2023 but they do not have a material
effect on the Group's financial statements.
Taxes on income in the interim
period are accrued using the tax rate that would be applicable to
expected total annual earnings.
This condensed interim consolidated financial information
has been prepared on a going concern basis under
the historical cost convention, as modified by the recognition of
certain financial assets and financial liabilities (including
derivative financial instruments) at fair value through profit or
loss.
The preparation of
condensed interim consolidated financial
information, in conformity with generally
accepted accounting principles, requires the use of estimates and
assumptions that affect the reported amounts of assets and
liabilities at the date of the condensed
interim consolidated financial information, and the reported amounts of revenues and expenses during the
reporting period. Although these estimates are based on
management's best knowledge of the amount, event or actions, actual
results may ultimately differ from those estimates.
In preparing the condensed interim financial
statements, the significant judgements made by management in
applying the Group's accounting policies and the key sources of
estimation uncertainty were the same as those applied to the
consolidated financial statements for the year ended 30 November
2023.
After having made appropriate
enquiries, including a review of progress against the Group's
budget for 2024, its current trading and medium-term plans; taking
into account the banking facilities available until May 2025,
together with the positive progress being made to renew the four
year secured revolving credit facility, with an option to extend by
one year, the Directors have a reasonable expectation that the
Group has adequate resources to continue in operational existence
for at least twelve months from the date of approval of the
condensed interim consolidated financial information. Accordingly,
they continue to adopt the going concern basis in preparing this
condensed interim consolidated financial information.
This condensed interim consolidated financial information
and the comparative figures do not constitute
full accounts within the meaning of Section 434 of the Companies
Act 2006. Statutory accounts for the year ended 30 November
2023, which were approved by the Board of Directors on 2 February
2024, and which include an unqualified audit report, no emphasis of
matter paragraph and no statements under sections 498(2) or (3) of
the Companies Act 2006, have been delivered to the Registrar of
Companies. This condensed interim
consolidated financial information has been reviewed, not
audited.
The condensed interim consolidated
financial information does not include all financial risk
management information and disclosures required in the annual
financial statements; it should be read in conjunction with the
Group's annual financial statements for the year ended 30 November
2023. There have been no changes in any risk management
policies since the year end.
This report will be available at
Porvair plc's registered office at 7 Regis Place, Bergen Way,
King's Lynn, PE30 2JN and on the Company's website,
www.porvair.com.
Statement of directors' responsibilities
The Directors confirm that
this condensed interim consolidated
financial information has been prepared in
accordance with IAS 34 Interim
Financial Reporting as contained in
UK-adopted International Accounting Standards, and that the interim management report herein includes a
fair review of the information required by DTR 4.2.7 and DTR 4.2.8,
namely:
·
an indication of important events that have
occurred during the first six months of the year, their impact on
the condensed interim consolidated
financial information and a description of
the principal risks and uncertainties for the remaining six months
of the financial year; and
·
material related party transactions in the first
six months of the year and any material changes in the related
party transactions described in the last annual report.
The Directors of Porvair plc are
listed in the Porvair plc Annual Report for the year ended 30
November 2023. Since the publication of the Annual Report for
the year ended 30 November 2023, Sarah Vawda resigned
from the Board. A
list of current Directors is maintained on the Porvair plc
website, www.porvair.com.
By order of the board
Ben
Stocks
|
James Mills
|
Group Chief Executive
28 June 2024
|
Group Finance Director
|
INDEPENDENT REVIEW REPORT TO PORVAIR PLC
Conclusion
We have been engaged by Porvair plc ('the Company')
to review the condensed set of financial statements of the Company
and its subsidiaries (the 'Group') in the interim financial report
for the six months ended 31 May 2024 which comprises the condensed
consolidated income statement, the condensed consolidated statement
of comprehensive income, the condensed consolidated balance sheet,
the condensed consolidated cash flow statement, the condensed
consolidated statement of changes in equity and related notes 1 to
11. We have read the other information contained in the
interim financial report and considered whether it contains any
apparent misstatements of fact or material inconsistencies with the
information in the condensed set of financial statements.
Based on our review, nothing has come to our
attention that causes us to believe that the condensed set of
financial statements in the interim financial report for the six
months ended 31 May 2024 is not prepared, in all material respects,
in accordance with International Accounting Standard 34, "Interim
Financial Reporting" as contained in UK-adopted International
Accounting Standards, and the Disclosure Guidance and Transparency
Rules of the United Kingdom's Financial Conduct Authority.
Basis for Conclusion
We conducted our review in accordance with
International Standard on Review Engagements (UK) 2410, "Review of
Interim Financial Information Performed by the Independent Auditor
of the Entity" ('ISRE (UK) 2410') issued for use in the United
Kingdom. A review of interim financial information consists
of making enquiries, primarily of persons responsible for financial
and accounting matters, and applying analytical and other review
procedures. A review is substantially less in scope than an
audit conducted in accordance with International Standards on
Auditing (UK) and consequently does not enable us to obtain
assurance that we would become aware of all significant matters
that might be identified in an audit. Accordingly, we do not
express an audit opinion.
As disclosed in note 11, the
annual financial statements of the Group are prepared in accordance
with UK-adopted International Accounting Standards. The
condensed set of financial statements included in this interim
financial report has been prepared in accordance with International
Accounting Standard 34, "Interim Financial Reporting" as contained
in UK-adopted International Accounting Standards.
Conclusions Relating to Going Concern
Based on our review procedures,
which are less extensive than those performed in an audit as
described in the Basis for Conclusion section of this report,
nothing has come to our attention to suggest that management have
inappropriately adopted the going concern basis of accounting or
that management have identified material uncertainties relating to
going concern that are not appropriately disclosed.
This conclusion is based on the
review procedures performed in accordance with ISRE (UK) 2410,
however future events or conditions may cause the Group and the
Company to cease to continue as a going concern.
Responsibilities of Directors
The interim financial report, is
the responsibility of, and has been approved by, the
directors. The directors are responsible for preparing the
interim financial report in accordance with International
Accounting Standard 34, "Interim Financial Reporting" as contained
in UK-adopted International Accounting Standards and the Disclosure
Guidance and Transparency Rules of the United Kingdom's Financial
Conduct Authority.
In preparing the interim financial
report, the directors are responsible for assessing the Group's and
the Company's ability to continue as a going concern, disclosing,
as applicable, matters related to going concern and using the going
concern basis of accounting unless the directors either intend to
liquidate the Group or the Company or to cease operations, or have
no realistic alternative but to do so.
Auditor's Responsibilities for the Review of the Financial
Information
In reviewing the interim financial
report, we are responsible for expressing to the Company a
conclusion on the condensed set of financial statements in the
interim financial report. Our conclusion, including our
Conclusions Relating to Going Concern, are based on procedures that
are less extensive than audit procedures, as described in the Basis
for Conclusion paragraph of this report.
Use of our report
This report is made solely to the
Company in accordance with International Standard on Review
Engagements (UK) 2410 "Review of Interim Financial Information
performed by the Independent Auditor of the Entity". Our
review work has been undertaken so that we might state to the
Company those matters we are required to state to them in an
independent review report and for no other purpose. To the fullest
extent permitted by law, we do not accept or assume responsibility
to anyone other than the Company, for our review work, for this
report, or for the conclusions we have formed.
RSM UK Audit LLP
Chartered Accountants
25 Farringdon Street
London EC4A 4AB
28 June 2024